Hydroxychloroquine (for bibliographic search)

Table Graph
Published MAOR95% CInkI2ROB All congenital malformations (majors, minors, majors and minors, or unspecified) metaPreg 1.26[1.08; 1.48]180%0- Sperber (Autoimmune diseases), 2009versus whatever (meta-analysis) 0.66[0.25; 1.75]40%0- Duan (SLE indication), 2021versus unexposed, sick 0.53[0.14; 2.04]40%0- Major congenital malformations metaPreg 1.26[1.06; 1.50]122%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 1.13[0.59; 2.17]616%0- Nervous system anomalies metaPreg 2.66[0.11; 65.66]1-0- Kaplan (All indications), 2016versus whatever (meta-analysis) 1.81[0.31; 10.52]30%0- Congenital heart defects metaPreg 1.37[0.75; 2.49]30%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 1.06[0.29; 3.86]40%0- Intrauterine deaths (as a whole or unspecified) metaPreg 0.62[0.39; 1.00]1364%0- Clowse (All SLE (lupus) pregnancies), 2022versus whatever (meta-analysis) 0.83[0.63; 1.09]7-0- Clowse (Antiphospholipid syndrome), 2022versus whatever (meta-analysis) Out of scale0.46[0.10; 2.06]--0- Early intrauterine death (< 22 weeks) metaPreg 0.97[0.62; 1.52]1659%0- Sperber (Autoimmune diseases), 2009versus whatever (meta-analysis) 0.92[0.49; 1.72]40%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 1.85[1.10; 3.13]413%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 1.77[1.09; 2.88]40%0- Duan (SLE indication), 2021versus unexposed, sick 1.77[0.96; 3.26]535%0- Duan (SLE indication), 2021versus unexposed, sick 0.58[0.24; 1.39]20%0- Late intrauterine deaths (> 22 weeks) metaPreg 0.78[0.46; 1.33]140%0- Sperber (Autoimmune diseases), 2009versus whatever (meta-analysis) 0.94[0.14; 6.54]472%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 0.69[0.35; 1.34]60%0- Duan (SLE indication), 2021versus unexposed, sick 1.00[0.50; 2.00]60%0- Preterm (< 37 weeks) metaPreg 0.91[0.70; 1.18]2764%0- Sperber (Autoimmune diseases), 2009versus whatever (meta-analysis) 1.08[0.74; 1.57]40%0- Guillotin (SLE indication), 2018versus whatever (meta-analysis) 0.54[0.26; 1.15]654%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 1.75[0.95; 3.24]572%0- Clowse (All SLE (lupus) pregnancies), 2022versus whatever (meta-analysis) 0.68[0.39; 1.18]7-0- Clowse (Antiphospholipid syndrome), 2022versus whatever (meta-analysis) 0.88[0.09; 8.97]--0- Naveau (SLE indication), 2020versus whatever (meta-analysis) 0.61[0.40; 0.93]-47%0- Tian (Antiphospholipid antibody syndrome), 2021versus whatever (meta-analysis) Out of scale0.43[0.13; 1.37]250%0- Duan (SLE indication), 2021versus unexposed, sick 0.55[0.36; 0.86]841%0- Low birth weight (< 2500g) metaPreg 0.78[0.45; 1.34]656%0- Guillotin (SLE indication), 2018versus whatever (meta-analysis) 0.62[0.24; 1.64]566%0- Kaplan (All indications), 2016versus whatever (meta-analysis) 0.69[0.21; 2.27]272%0- Duan (SLE indication), 2021versus unexposed, sick 0.77[0.43; 1.39]538%0- Small for gestational age (weight) metaPreg 0.84[0.63; 1.11]2241%0- Tian (Antiphospholipid antibody syndrome), 2021versus whatever (meta-analysis) Out of scale0.22[0.13; 1.88]20%0- Duan (SLE indication), 2021versus unexposed, sick 0.57[0.06; 5.43]388%0- Gestational diabetes metaPreg 0.87[0.76; 0.99]40%0- Duan (SLE indication), 2021versus unexposed, sick 2.30[0.44; 12.12]20%0- Duan (SLE indication), 2021versus unexposed, sick 0.88[0.19; 3.96]20%0- Duan (SLE indication), 2021versus unexposed, sick Out of scale0.26[0.05; 1.51]27%0- Preeclampsia metaPreg Out of scale0.44[0.29; 0.68]2042%0- Duan (SLE indication), 2021versus unexposed, sick Out of scale0.35[0.21; 0.59]622%0- Clowse (All SLE (lupus) pregnancies), 2022versus whatever (meta-analysis) 0.89[0.62; 1.29]7-0- Clowse (Antiphospholipid syndrome), 2022versus whatever (meta-analysis) 0.60[0.28; 1.28]--0- Naveau (SLE indication), 2020versus whatever (meta-analysis) Out of scale0.49[0.59; 1.01]-49%0- Liu (SLE indication), 2021versus unexposed, sick 0.61[0.34; 1.11]311%0- Fetal distress metaPreg 0.63[0.33; 1.19]30%0- Duan (SLE indication), 2021versus unexposed, sick 1.07[0.41; 2.76]50%0- Low Apgar score (< 7) (at 5 min) metaPreg Out of scale0.41[0.23; 0.72]40%0- Duan (SLE indication), 2021versus unexposed, sick 0.72[0.20; 2.58]20%0- Oligohydramnios metaPreg 0.54[0.15; 1.96]20%0- Duan (SLE indication), 2021versus unexposed, sick 0.90[0.38; 2.14]340%0-0.55.01.0

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons